Simple jQuery Dropdowns
Please use this identifier to cite or link to this item: http://repository.li.mahidol.ac.th/dspace/handle/123456789/26758
Full metadata record
DC FieldValueLanguage
dc.contributor.authorViroj Tangcharoensathienen_US
dc.contributor.authorWiput Phoolcharoenen_US
dc.contributor.authorSiriwan Pitayarangsariten_US
dc.contributor.authorSukhontha Kongsinen_US
dc.contributor.authorVijj Kasemsupen_US
dc.contributor.authorSripen Tantivessen_US
dc.contributor.authorChutima Suraratdechaen_US
dc.contributor.otherThailand Health Systems Research Instituteen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherSukhothai Thammatirat Open Universityen_US
dc.date.accessioned2018-09-07T09:47:51Z-
dc.date.available2018-09-07T09:47:51Z-
dc.date.issued2001-06-15en_US
dc.identifier.citationHealth Policy. Vol.57, No.2 (2001), 111-139en_US
dc.identifier.issn01688510en_US
dc.identifier.other2-s2.0-0034990341en_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0034990341&origin=inwarden_US
dc.identifier.urihttp://repository.li.mahidol.ac.th/dspace/handle/123456789/26758-
dc.description.abstractThe recent ongoing phase III clinical trial of a preventive vaccine in Thailand has prompted studies on potential demand for the vaccine among public, employers and households. This study aims to demonstrate the impact of HIV/AIDS, estimate the AIDS vaccine budget required and design the vaccination strategies for different population groups. The analysis is based on available secondary data and several assumptions on levels of secondary infections among various risk groups. Among 15 groups, we identified eight groups as potential vaccinees: Direct CSW, IDU in treatment, IDU out of treatment, male STD, transport workers, CSW indirect, conscripts and prisoners. The vaccine budget, excluding other operating expenditure, was estimated based on a single dose regimen ranging from 100 Baht (US$3) to 1000 Baht (US$29) per dose. A total of US$1.8-17.7 million is required for non-infected catch-up population and US$0.2-1.9 million for the maintenance population in the subsequent year. We foresee a relative inefficient and inequitable consumption of AIDS vaccine, which requires proper policy analysis and government interventions. Before vaccine adoption, strong preventive measures must be in place. AIDS vaccine could play an additional, not a substituting, role. A thorough understanding, a wide consultation with stakeholders and public debates are crucial steps for sound policy formulation. Copyright © 2001 Elsevier Science Ireland Ltd.en_US
dc.rightsMahidol Universityen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0034990341&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleThe potential demand for an AIDS vaccine in Thailanden_US
dc.typeShort Surveyen_US
dc.rights.holderSCOPUSen_US
dc.identifier.doi10.1016/S0168-8510(01)00119-1en_US
Appears in Collections:Scopus 2001-2005

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.